Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
21 hedge funds and large institutions have $6.32M invested in Psychemedics Corporation in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
5% more funds holding
Funds holding: 20 → 21 (+1)
14% less capital invested
Capital invested by funds: $7.34M → $6.32M (-$1.02M)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
Top Sellers
| 1 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
-$72K |
| 2 |
Renaissance Technologies
New York
|
-$16.7K |
| 3 |
WE
Wealth Effects
Boston,
Massachusetts
|
-$15.2K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.06K |
| 5 |
BlackRock
New York
|
-$2.02K |
PMD Hedge Fund Activity: Q2 2023 in Review
21 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q2 2023, worth a combined $6.32M — down 14% from $7.34M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PMD positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Wedbush Securities, adding an estimated $24K. The largest seller was Crawford Investment Counsel, cutting an estimated $72K.
- 21 institutional investors held Psychemedics Corporation (PMD) as of Q2 2023, up from 20 in Q1 2023.
- Funds reported $6.32M of Psychemedics Corporation stock for Q2 2023, down 14% quarter-over-quarter.
- 2 funds opened new Psychemedics Corporation positions in Q2 2023 and 1 closed out, a net change of +1 holder.
- The largest Psychemedics Corporation buyer in Q2 2023 was Wedbush Securities, an estimated $24K added.
- The largest Psychemedics Corporation seller in Q2 2023 was Crawford Investment Counsel, an estimated $72K sold.
Based on aggregated 13F filings for Q2 2023.